2.50

1.57% -0.04

Pre-market: 2.47 -0.03 -1.20%

Biomerica Inc (BMRA)

Overview News Price History Option Chain Financials Why BMRA Down? Discussions Forecast Stock Split

Biomerica Inc stock is traded at $2.50, with a volume of 7,900. It is down -1.57% in the last 24 hours and up +1.21% over the past month. Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.

Previous Close:

$2.54

Open:

$2.44

24h Volume:

7,900

Relative Volume:

0.08

Market Cap:

$7.37M

Revenue:

$4.88M

Net Income/Loss:

$-3.66M

P/E Ratio:

-1.6292

EPS:

-1.5345

Net Cash Flow:

$-2.80M

1W Performance:

+8.23%

1M Performance:

+1.21%

6M Performance:

-27.11%

1Y Performance:

+4.10%

1-Day Range:

$2.4283

$2.5731

1-Week Range:

$2.26

$2.60

52-Week Range:

$2.08

$10.16

Biomerica Inc Stock (BMRA) Company Profile

Name

Biomerica Inc

Sector

Healthcare (1124)

Industry

Medical Devices (143)

Phone

(949) 379-2875

Address

17571 VON KARMAN AVENUE, IRVINE, CA

Employee

Twitter

@biomerica_inc

Next Earnings Date

2025-04-16

Latest SEC Filings

BMRA's Discussions on Twitter

Compare BMRA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BMRA Biomerica Inc	2.50	7.49M	4.88M	-3.66M	-2.80M	-1.5345
ABT Abbott Laboratories	122.55	210.84B	43.84B	13.90B	6.92B	7.9725
BSX Boston Scientific Corp	92.70	137.17B	19.35B	2.78B	3.82B	1.8696
SYK Stryker Corp	353.80	133.55B	24.38B	2.94B	4.07B	7.6159
MDT Medtronic Plc	100.77	127.71B	34.76B	4.79B	5.21B	3.7017
EW Edwards Lifesciences Corp	83.92	48.33B	5.88B	1.34B	799.60M	2.3489

Biomerica Inc Stock (BMRA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-10-20	Initiated	Colliers Securities	Buy
Jan-04-18	Initiated	B. Riley FBR, Inc.	Buy

Biomerica Inc Stock (BMRA) Latest News

Dec 09, 2025

Biomerica (NASDAQ:BMRA) versus ProKidney (NASDAQ:PROK) Critical Review - Defense World

Dec 09, 2025

Dec 06, 2025

Retail Trends: Why Biomerica Inc stock is recommended by analystsRisk Management & Target Return Focused Stock Picks - BỘ NỘI VỤ

Dec 06, 2025

Dec 05, 2025

Why Biomerica Inc. stock is recommended by analystsJuly 2025 Drop Watch & Free Expert Verified Stock Movement Alerts - Newser

Dec 05, 2025

Is Biomerica Inc. stock a good choice for value investorsJuly 2025 Big Picture & AI Enhanced Trading Alerts - Newser

Dec 05, 2025

Dec 03, 2025

Biomerica (BMRA) Stock Analysis Report | Ratings, Financials & Performance - Benzinga

Dec 03, 2025

Dec 01, 2025

Biomerica Expands Contract Manufacturing Services - Orange County Business Journal

Dec 01, 2025

Nov 27, 2025

Is Biomerica Inc. stock a safe haven asset2025 Trading Volume Trends & Safe Capital Investment Plans - BỘ NỘI VỤ

Nov 27, 2025

Nov 25, 2025

Biomerica's inFoods IBS Product Featured in Biotherapeutics Quarterly - MarketScreener

Nov 25, 2025

Biomerica (BMRA) Showcases Innovative IBS Therapy in Biotherapeu - GuruFocus

Nov 25, 2025

Biomerica, Inc. Announces Positive Results from Multicenter Clinical Trial on inFoods® IBS Dietary Therapy - Quiver Quantitative

Nov 25, 2025

Nov 21, 2025